Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy
Molecules · 2025
DOI: 10.3390/molecules30183821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ricky Wirawan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians University, Butenandtstr. 5-13, 81377 Munich, Germany. Hauptthemen laut MEDLINE: Sirtuins, Histone Deacetylase Inhibitors. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Sirtuin 5 is an NAD+-dependent lysine deacylase that is involved in various biological processes and has emerged as a promising target for pharmaceutical therapies. The development of highly potent and subtype-selective sirtuin 5 inhibitors for their application as chemical tools and drug candidates still poses a significant challenge. Based on our own optimized balsalazide-derived sirtuin 5 inhibitors, this work presents a systematic investigation of the inhibitory effects of derivatives with moieties that were guided by docking experiments to target the nicotinamide ribose vicinal hydroxy groups of the essential co-factor NAD+ via reversible covalent binding to potentially enhance their potency. Our results show that functionalizations with these moieties were tolerated to some extent and possessed a distinct stereo-selective preference. The (S)-configured cyanomethyl derivative 50 with an IC50 of 27 µM emerged from our synthesized library of compounds as the most potent functionalized inhibitor and lies in a similar potency range to other established sirtuin 5 inhibitors. Our findings offer a deeper insight into the structure–activity relationships of our balsalazide-derived heterotriaryl-based sirtuin 5 inhibitors and thus could provide an avenue for further optimizations in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians University, Butenandtstr. 5-13, 81377 Munich, Germany.
ORCID-Profile: Ricky Wirawan, Thomas Wein, Franz Bracher
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Wirawan, R., Huber, S. A., Wein, T., & Bracher, F. (2025). Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy. Molecules. https://doi.org/10.3390/molecules30183821
Vancouver
Wirawan R, Huber SA, Wein T, Bracher F. Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy. Molecules. 2025. doi:10.3390/molecules30183821
BibTeX
@article{Wirawan2025,
author = {Wirawan, Ricky and Huber, Simon A and Wein, Thomas and Bracher, Franz},
title = {Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30183821}
}
EUVIMED